CDAN: Convolutional Dense Attention-guided Network for Low-light Image Enhancement

Low-light images, characterized by inadequate illumination, pose challenges of diminished clarity, muted colors, and reduced details. Low-light image enhancement, an essential task in computer vision, aims to rectify these issues by improving brightness, contrast, and overall perceptual quality, thereby facilitating accurate analysis and interpretation. This paper introduces the Convolutional Dense Attention-guided Network (CDAN), a novel solution for enhancing low-light images. CDAN integrates an autoencoder-based architecture with convolutional and dense blocks, complemented by an attention mechanism and skip connections. This architecture ensures efficient information propagation and feature learning. Furthermore, a dedicated post-processing phase refines color balance and contrast. Our approach demonstrates notable progress compared to state-of-the-art results in low-light image enhancement, showcasing its robustness across a wide range of challenging scenarios. Our model performs remarkably on benchmark datasets, effectively mitigating under-exposure and proficiently restoring textures and colors in diverse low-light scenarios. This achievement underscores CDAN's potential for diverse computer vision tasks, notably enabling robust object detection and recognition in challenging low-light conditions.

Dual Branch Deep Learning Network for Detection and Stage Grading of Diabetic Retinopathy

Diabetic retinopathy is a severe complication of diabetes that can lead to permanent blindness if not treated promptly. Early and accurate diagnosis of the disease is essential for successful treatment. This paper introduces a deep learning method for the detection and stage grading of diabetic retinopathy, using a single fundus retinal image. Our model utilizes transfer learning, employing two state-of-the-art pre-trained models as feature extractors and fine-tuning them on a new dataset. The proposed model is trained on a large multi-center dataset, including the APTOS 2019 dataset, obtained from publicly available sources. It achieves remarkable performance in diabetic retinopathy detection and stage classification on the APTOS 2019, outperforming the established literature. For binary classification, the proposed approach achieves an accuracy of 98.50%, a sensitivity of 99.46%, and a specificity of 97.51%. In stage grading, it achieves a quadratic weighted kappa of 93.00%, an accuracy of 89.60%, a sensitivity of 89.60%, and a specificity of 97.72%. The proposed approach serves as a reliable screening and stage grading tool for diabetic retinopathy, offering significant potential to enhance clinical decision-making and patient care.